Browsing by Author "Mahmud, Farid H."

Now showing 1 - 5 of 5
  • Thumbnail Image
    Item
    International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Glycemic Targets
    (Karger, 2024) de Bock, Martin; Agwu, Juliana Chizo; Deabreu, Matt; Dovc, Klemen; Maahs, David M.; Marcovecchio, M. Loredana; Mahmud, Farid H.; Nóvoa-Medina, Yeray; Priyambada, Leena; Smart, Carmel E.; DiMeglio, Linda A.; Pediatrics, School of Medicine
    The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and updates recommendations on the glycemic targets for children and adolescents living with diabetes. A new target for hemoglobin A1c (HbA1c) of ≤6.5% (48 mmol/mol) is recommended for those who have access to advanced diabetes technologies like continuous glucose monitoring and automated insulin delivery. This target should be encouraged for all children and adolescents living with diabetes when safely achievable. In other settings, the HbA1c target is ≤7.0% (53 mmol/mol). The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and updates recommendations on the glycemic targets for children and adolescents living with diabetes. A new target for hemoglobin A1c (HbA1c) of ≤6.5% (48 mmol/mol) is recommended for those who have access to advanced diabetes technologies like continuous glucose monitoring and automated insulin delivery. This target should be encouraged for all children and adolescents living with diabetes when safely achievable. In other settings, the HbA1c target is ≤7.0% (53 mmol/mol).
  • Thumbnail Image
    Item
    ISPAD Clinical Practice Consensus Guidelines 2022: Editorial
    (Wiley, 2022) Craig, Maria E.; Codner, Ethel; Mahmud, Farid H.; Marcovecchio, M. Loredana; DiMeglio, Linda A.; Priyambada, Leena; Wolfsdorf, Joseph I.; Pediatrics, School of Medicine
  • Thumbnail Image
    Item
    ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes
    (Wiley, 2023) de Bock, Martin; Codner, Ethel; Craig, Maria E.; Huynh, Tony; Maahs, David M.; Mahmud, Farid H.; Marcovecchio, Loredana; DiMeglio, Linda A.; Pediatrics, School of Medicine
  • Thumbnail Image
    Item
    ISPAD Clinical Practice Consensus Guidelines 2024: Type 2 Diabetes in Children and Adolescents
    (Karger, 2024) Shah, Amy S.; Barrientos-Pérez, Margarita; Chang, Nancy; Fu, Jun-Fen; Hannon, Tamara S.; Kelsey, Megan; Peña, Alexia S.; Pinhas-Hamiel, Orit; Urakami, Tatsuhiko; Wicklow, Brandy; Wong, Jencia; Mahmud, Farid H.; Pediatrics, School of Medicine
    Youth-onset type 2 diabetes (T2D) results from genetic, environmental, and metabolic causes that differ among individuals and populations. This chapter builds on the 2022 ISPAD guidelines and summarizes recent advances in the management of T2D in children and adolescents. Updates include diagnostic algorithm for youth with new onset T2D, algorithms and tables for treatment, management, and assessment of comorbidities and complications and recommendations on recently approved pharmacologic therapies for the treatment of youth-onset T2D and management strategies. Youth-onset type 2 diabetes (T2D) results from genetic, environmental, and metabolic causes that differ among individuals and populations. This chapter builds on the 2022 ISPAD guidelines and summarizes recent advances in the management of T2D in children and adolescents. Updates include diagnostic algorithm for youth with new onset T2D, algorithms and tables for treatment, management, and assessment of comorbidities and complications and recommendations on recently approved pharmacologic therapies for the treatment of youth-onset T2D and management strategies.
  • Thumbnail Image
    Item
    ISPAD Clinical Practice Guidelines 2024: Editorial
    (Karger, 2024) Mahmud, Farid H.; Dovc, Klemen; Marcovecchio, M. Loredana; Priyambada, Leena; Smart, Carmel E.; DiMeglio, Linda A.; Pediatrics, School of Medicine